H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 234 Citations 248,602 833 World Ranking 20 National Ranking 15

Research.com Recognitions

Awards & Achievements

2006 - Distinguished Fellowship Award, American College of Cardiology (ACC)

1999 - Fellow of the American Association for the Advancement of Science (AAAS)

1982 - Fellow of American Physical Society (APS)

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Enzyme

His primary areas of investigation include Internal medicine, Immunology, Inflammation, Endocrinology and Atheroma. The study incorporates disciplines such as Placebo, Surgery and Cardiology in addition to Internal medicine. His research in Immunology intersects with topics in Endothelium and Macrophage.

His Inflammation study incorporates themes from Disease, Pathology, Immune system and CD40. Peter Libby has included themes like Vascular disease and Intensive care medicine in his Disease study. His study in Endocrinology is interdisciplinary in nature, drawing from both Peroxisome proliferator-activated receptor, HMG-CoA reductase, Cytokine and Cell biology.

His most cited work include:

  • Inflammation and Atherosclerosis (6124 citations)
  • Inflammation in atherosclerosis (5682 citations)
  • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (4538 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Inflammation, Immunology, Pathology and Endocrinology are his primary areas of study. Peter Libby interconnects Placebo and Cardiology in the investigation of issues within Internal medicine. His Cardiology research incorporates elements of Thrombosis and Rosuvastatin.

His Inflammation research includes elements of Tumor necrosis factor alpha, Disease, Vascular disease and Cell biology. Peter Libby has researched Immunology in several fields, including Macrophage and Transplantation. In his research on the topic of Pathology, Extracellular matrix is strongly related with Matrix metalloproteinase.

He most often published in these fields:

  • Internal medicine (36.10%)
  • Inflammation (23.50%)
  • Immunology (22.73%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (36.10%)
  • Inflammation (23.50%)
  • Immunology (22.73%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Inflammation, Immunology, Myocardial infarction and Disease. His biological study spans a wide range of topics, including Placebo, Endocrinology and Cardiology. His study on Inflammation also encompasses disciplines like

  • Pathology together with Atheroma,
  • Thrombosis that intertwine with fields like Neutrophil extracellular traps and Endothelium.

His Immunology and Immune system and Monocyte investigations all form part of his Immunology research activities. His work on Myocardial infarction is being expanded to include thematically relevant topics such as Stroke. The study incorporates disciplines such as Risk factor and Intensive care medicine in addition to Disease.

Between 2015 and 2021, his most popular works were:

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (3050 citations)
  • Clonal Hematopoiesis and risk of atherosclerotic cardiovascular disease (728 citations)
  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial (508 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Enzyme

Peter Libby mostly deals with Internal medicine, Inflammation, Disease, Immunology and Myocardial infarction. Internal medicine is closely attributed to Cardiology in his research. His Inflammation research includes themes of Innate immune system, Bone marrow, Pathology and Immunity.

His Pathology research is multidisciplinary, incorporating perspectives in Endothelium, Plaque rupture, Plaque erosion and In vivo. The concepts of his Disease study are interwoven with issues in Ageing, Stem cell, Bioinformatics and Intensive care medicine. His Myocardial infarction research also works with subjects such as

  • Heart failure which is related to area like Macrophage,
  • Thrombosis together with Endothelial stem cell and Atheroma.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Inflammation and Atherosclerosis

Peter Libby;Paul M. Ridker;Attilio Maseri.
Circulation (2002)

21200 Citations

Inflammation in atherosclerosis

Peter Libby.
Nature (2002)

9710 Citations

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Paul M Ridker;Eleanor Danielson;Jacques Genest;Antonio M. Gotto.
The New England Journal of Medicine (2008)

7489 Citations

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Paul M. Ridker;Eleanor Danielson;Francisco A. H. Fonseca;Jacques Genest.
Obstetrical & Gynecological Survey (2009)

6000 Citations

From Vulnerable Plaque to Vulnerable Patient A Call for New Definitions and Risk Assessment Strategies: Part I

Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells;S. Ward Casscells.
Circulation (2003)

4224 Citations

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Paul M Ridker;Brendan M. Everett;Tom Thuren;Jean G. MacFadyen.
The New England Journal of Medicine (2017)

3989 Citations

Progress and challenges in translating the biology of atherosclerosis

Peter Libby;Paul M Ridker;Göran K. Hansson.
Nature (2011)

3626 Citations

Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management

Joshua A. Beckman;Mark A. Creager;Peter Libby.
JAMA (2002)

3595 Citations

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Z S Galis;Galina K. Sukhova;M W Lark;Peter Libby.
Journal of Clinical Investigation (1994)

3183 Citations

Molecular bases of the acute coronary syndromes

Peter Libby.
Circulation (1995)

3057 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Peter Libby

Paul M. Ridker

Paul M. Ridker

Harvard Medical School

Publications: 296

Christian Weber

Christian Weber

Ludwig Maximilian University of Munich

Publications: 287

Thomas F. Lüscher

Thomas F. Lüscher

University of Zurich

Publications: 259

Stephen J. Nicholls

Stephen J. Nicholls

Monash University

Publications: 256

Zahi A. Fayad

Zahi A. Fayad

Icahn School of Medicine at Mount Sinai

Publications: 250

Valentin Fuster

Valentin Fuster

Icahn School of Medicine at Mount Sinai

Publications: 220

Ziad Mallat

Ziad Mallat

University of Cambridge

Publications: 193

Göran K. Hansson

Göran K. Hansson

Karolinska University Hospital

Publications: 176

Jan Nilsson

Jan Nilsson

Lund University

Publications: 176

Matthias Nahrendorf

Matthias Nahrendorf

Harvard University

Publications: 173

Charles A. Dinarello

Charles A. Dinarello

University of Colorado Denver

Publications: 169

Patrick W. Serruys

Patrick W. Serruys

National University of Ireland, Galway

Publications: 163

Pål Aukrust

Pål Aukrust

Oslo University Hospital

Publications: 162

Renu Virmani

Renu Virmani

CVPath Institute

Publications: 157

Lina Badimon

Lina Badimon

Instituto de Salud Carlos III

Publications: 148

Something went wrong. Please try again later.